All News

Honoring Olivia Newton-John, My Cancer Icon

August 9th 2022

Hearing the news of Olivia Newton-John’s death shocked me. I’d loved this lady since the early 70s. But shock wasn’t the only emotion I faced — along with it came overwhelming sadness and fear.

Oral Fruquintinib Provides ‘Potential New Option’ With ‘Added Convenience’ for Patients With Relapsed/Refractory Colorectal Cancer

August 9th 2022

Fruquintinib improved survival in patients with advanced colorectal cancer, according to findings from the phase 3 FRESCO-2 trial.

Sugemalimab Demonstrates Improved Progression-Free Survival in Some Patients with Non-Small Cell Lung Cancer

August 9th 2022

Sugemalimab demonstrated safe and efficacious results when given after concurrent chemoradiation therapy or short-course chemoradiation therapy for patients with lung cancer.

Olivia Newton-John Dies Decades After Receiving a Breast Cancer Diagnosis

August 8th 2022

Actress/musician Olivia Newton-John has died after a long bout with breast cancer.

Investigational Drug-Libtayo Combo Demonstrates Clinical Activity in Metastatic Prostate Cancer

August 8th 2022

Treatment with an investigational drug plus with Libtayo showed encouraging anti-tumor activity in patients with advanced metastatic castration-resistant prostate cancer, according to preliminary data from an early-phase trial.

Cancer Is Like a Hula Hoop, and I Need to Stay Inside My Circle

August 8th 2022

It’s hard to watch other people fight cancer, but I must remember to stay inside my safe zone — my hula hoop — and only run to aid them when they ask.

Few Patients With Breast Cancer Are Educated on Treatments' Impacts on Sexual Health

August 8th 2022

Although very few patients are informed about the effects that breast cancer treatments may have on their sexual health, many patients expressed wanting that information throughout all stages of their treatment, according to study findings.

Keytruda Plus Chemotherapy Is Not Superior to Chemotherapy Alone in Metastatic Prostate Cancer

August 8th 2022

Keytruda plus chemotherapy failed to best the chemotherapy docetaxel alone in patients with metastatic castration-resistant prostate cancer, according to findings of a study of more than 1,000 patients.

An Exemplary Oncology Nurse Navigator

August 7th 2022

Kimberly is a true asset to our patients. She helps them to face the complicated health care system, making sure patients can get all the testing and treatment they need.

A Champion of Champions in the Oncology World

August 6th 2022

As an oncology nurse, which is emotionally taxing and rewarding work, she manages to sprinkle kindness at all times.

An Online Group Helped Me Get Rid of Post-Mastectomy Items I Didn’t Need

August 5th 2022

I made too many late-night purchases for things that I thought I’d need after my mastectomy. Thankfully, the STOMP group helped me get rid of some of these items.

FDA Approves Nubeqa Tablet Regimen for Metastatic Hormone-Sensitive Prostate Cancer

August 5th 2022

The Food and Drug Administration approved oral Nubeqa plus the chemotherapy docetaxel for patients with metastatic hormone-sensitive prostate cancer.

FDA Approves Enhertu for HER2-Low Metastatic Breast Cancer

August 5th 2022

The Food and Drug Administration approved Enhertu for the treatment of unresectable or metastatic HER2-low breast cancer — marking the first targeted drug for this newly defined breast cancer subtype.

Leukemia Survivor Meets Country Music Singer Luke Combs, Sarcoma Nonprofit to Honor Minecraft YouTube Celebrity Technoblade and More

August 5th 2022

From the late YouTuber “Technoblade” being honored by the Sarcoma Foundation of America to a country singer making a leukemia survivor’s dreams come true, here’s what’s happening in the cancer space this week.

FDA Approves Tablet Version of Calquence to Treat Multiple Blood Cancers

August 5th 2022

The tablet version of Calquence, which was approved by the FDA for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia and relapsed/refractory mantle cell lymphoma, may be taken alongside other drugs to reduce gastric-related side effects.

Onivyde Fails to Improve Survival Over Chemotherapy in Second-Line Small Cell Lung Cancer

August 5th 2022

Treatment with Onivyde failed to best the chemotherapy topotecan in improving overall survival in patients with small cell lung cancer whose disease failed to respond to platinum-based first-line treatment, according to findings from a primary analysis of the phase 3 RESILIENT trial.

Does My Cancer Give Me a Pass at Patience?

August 4th 2022

When my grandmother passed, I noticed my aunt was ruder than usual, and I wondered if I was like that during my cancer experience... and if the pain I was going through excused that behavior.

Genetic Testing May 'Open New Doors for New Treatments' in Prostate Cancer

August 4th 2022

In this video, an expert discusses which men with prostate cancer are eligible for genetic testing, and what patients can do if they are not eligible but want to undergo testing anyway.

Parallels Between the Psychology of Money and Life After Cancer

August 4th 2022

I recently read a book about the psychology of money, and actually related much of the content to my life after osteosarcoma.

Cancer-Related Pain Linked to Poor Employment and Financial Outcomes in Survivors

August 4th 2022

Cancer-related pain, especially when severe, is associated with negative effects on patients’ employment and financial status, recent findings showed.

Childhood Cancer Survivors Are at an Increased Risk for Hospitalization Due to Infection Several Years After Treatment Has Ended

August 4th 2022

Survivors of childhood cancer had higher rates of infection-related hospitalizations than their healthy peers, at both the five- and 10-year post-treatment mark.

Trial to Compare Safety and Efficacy of Novel Cell Therapy to Standard of Care in Patients With Rare Blood Cancers

August 3rd 2022

Enrollment has begun on a phase 3 clinical trial assessing the safety and efficacy of an investigational cell therapy in patients with acute myeloid leukemia, acute lymphocytic leukemia and myelodysplastic syndromes.

Most Women Unaware of Screening Recommendations to Detect Possible Rupture After Receiving Silicone Breast Implants

August 3rd 2022

Findings from a recently published study demonstrated that only a small percentage of women — all with breast cancer — who received silicone breast implants underwent the recommended screening to assess for potential ruptures.

Loving People in My Life Could Not Handle My Daughter’s Cancer

August 3rd 2022

Despite how caring they may be, certain people in our life had a difficult time being there for the realities of my daughter’s cancer experience.

Primary Radiotherapy Associated With Increased Risk For Secondary Primary Cancers Among Patients With Prostate Cancer

August 3rd 2022

Treatment with primary radiotherapy was linked to an increased risk for the development of secondary primary cancers among a large group of men with localized prostate cancer, according to recent study findings.

Coffee and Tea Consumption Are Not Associated With Harmful Quality of Life, Survival Outcomes Among Breast Cancer Survivors

August 3rd 2022

The findings add to a growing body of literature that demonstrate coffee and/or tea consumption is not detrimental to breast cancer survivors, according to the study authors.

Losing My Hair Helped Me Empathize With Others

August 2nd 2022

Losing my hair from breast cancer treatments was an emotional experience for me and helped me empathize with others who also lost their hair.

Outcomes Are Best When Patients With Cancer Are as Aware of Their Disease as Their Provider, Expert Says

August 2nd 2022

Patients with cancer are encouraged to learn more about their disease from evidenced-based sources and not “Dr. Google.”

The Incredible Shrinking Patient With Cancer

August 2nd 2022

Cancer treatment-related osteoporosis caused me to shrink two inches.

Injectable Tecentriq Is Efficacious, Reduces Treatment Time for Lung Cancer

August 2nd 2022

Subcutaneous (injectable) Tecentriq had similar movement throughout the body, while saving on treatment time compared to intravenous administration of the drug in a group of patients with non-small cell lung cancer.